FDA.reportPublic FDA data

ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count

RxCUI
2396253
RxNorm name
ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count
Display name
ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count
Full name
ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TwirlaLEVONORGESTREL/ETHINYL ESTRADIOLAgile Therapeutics, Inc.bcaf8db0-1750-425d-b008-255b5e7a9cc62026-06-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2396253

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bcaf8db0-1750-425d-b008-255b5e7a9cc6{3 (168 HR ethinyl estradiol 0.00125 MG/HR / levonorgestrel 0.005 MG/HR Transdermal System) } Pack [GPCK] · ethinyl estradiol 120 MCG / levonorgestrel 30 MCG per 24 HR Weekly Transdermal System, 3 Count [PSN]27These highlights do not include all the information needed to use TWIRLA ® safely and effectively. See full prescribing information for TWIRLA. TWIRLA (levonorgestrel and ethinyl estradiol) transdermal system Initial U.S. Approval: 1968 (norgestrel and ethinyl estradiol)20240703